Skip to main content
PLOS Global Public Health logoLink to PLOS Global Public Health
. 2023 Dec 28;3(12):e0002330. doi: 10.1371/journal.pgph.0002330

Exploring multimorbidity clusters in relation to healthcare use and its impact on self-rated health among older people in India

Salmaan Ansari 1, Abhishek Anand 2, Babul Hossain 2,*
Editor: Julia Robinson3
PMCID: PMC10754468  PMID: 38153935

Abstract

The conventional definition of multimorbidity may not address the complex treatment needs resulting from interactions between multiple conditions, impacting self-rated health (SRH). In India, there is limited research on healthcare use and SRH considering diverse disease combinations in individuals with multimorbidity. This study aims to identify multimorbidity clusters related to healthcare use and determine if it improves the self-rated health of individuals in different clusters. This study extracted information from cross-sectional data of the first wave of the Longitudinal Ageing Study in India (LASI), conducted in 2017–18. The study participants were 31,373 people aged ≥ 60 years. A total of nineteen chronic diseases were incorporated to identify the multimorbidity clusters using latent class analysis (LCA) in the study. Multivariable logistic regression was used to examine the association between identified clusters and healthcare use. A propensity score matching (PSM) analysis was utilised to further examine the health benefit (i.e., SRH) of using healthcare in each identified cluster. LCA analysis identified five different multimorbidity clusters: relatively healthy’ (68.72%), ‘metabolic disorder (16.26%), ‘hypertension-gastrointestinal-musculoskeletal’ (9.02%), ‘hypertension-gastrointestinal’ (4.07%), ‘complex multimorbidity’ (1.92%). Older people belonging to the complex multimorbidity [aOR:7.03, 95% CI: 3.54–13.96] and hypertension-gastrointestinal-musculoskeletal [aOR:3.27, 95% CI: 2.74–3.91] clusters were more likely to use healthcare. Using the nearest neighbor matching method, results from PSM analysis demonstrated that healthcare use was significantly associated with a decline in SRH across all multimorbidity clusters. Findings from this study highlight the importance of understanding multimorbidity clusters and their implications for healthcare utilization and patient well-being. Our findings support the creation of clinical practice guidelines (CPGs) focusing on a patient-centric approach to optimize multimorbidity management in older people. Additionally, finding suggest the urgency of inclusion of counseling and therapies for addressing well-being when treating patients with multimorbidity.

Introduction

Multimorbidity (i.e., the co-existence of two or more chronic conditions in an individual) is becoming progressively more common with advancing age and poses a key challenge to healthcare systems worldwide [1]. Given that the proportion of older people is expected to increase from 8% in 2015 to 19% in 2050, there may be a dramatic increase in the risk of developing multiple chronic conditions, such as cardiovascular diseases, diabetes, respiratory disorders, and musculoskeletal conditions over the coming decades [2]. When these conditions coexist in an individual, they often interact synergistically, resulting in poorer health outcomes and increased healthcare needs [3–7]. Moreover, individuals with multiple chronic conditions in India experienced higher rates of hospitalization, polypharmacy, outpatient visits and higher out-of-pocket expenditure (OOPE), and medical regimes [8–12]. These studies have shed light on the healthcare challenges faced by individuals with multimorbidity but have often relied on counting the number of concurrent conditions or examining the coexistence of two or more conditions. This approach may not fully capture the complexity of the patient’s healthcare needs and clinical management [13]. It is widely recognized that multimorbidity is highly heterogeneous and patients can experience a wide array of different combinations of diseases [14]. Therefore, the conventional definition of multimorbidity which typically requires the presence of two or more chronic conditions may not adequately capture the intricate treatment requirements necessitated by the complex interactions between multiple conditions [13].

In India, some studies have delved into the specific combinations of chronic non-communicable diseases (NCDs) and they used simply dyad or triad approach, or created dummy variables for identifying the pairs of the diseases [15–17]. While these methods are relatively simple and straightforward, they are typically limited to studying specific relationships, such as co-occurrence, and may not capture the complex spectrum of multimorbidity. Specifically, this approach may overlooked the broader context and potential synergistic effects of multiple health conditions on healthcare utilisation. In this context, there are some evidences from high-income countries utilised more complex statistical techniques such as Latent Class Analysis (LCA), network analysis, and k-means clustering and exploratory factor analysis [18–20]. These studies identified clinically justifiable multimorbidity patterns and observed variation in associated outcomes and healthcare needs across these clusters, providing insights into how certain conditions cluster together and their impact. These methods are often regarded as capable of uncovering complex and multivariate multimorbidity patterns. To our knowledge, no similar study has been conducted in India, with the exception of study by Puri et al. that was limited to examining patterns and associated factors among people aged 45 years or above [17]. From an etiological and clinical perspective, there is still limited knowledge to understand what makes health conditions tend to co-occur among older population, particularly in countries experiencing a growing aging population like India. Additionally, there is a need to comprehend the healthcare needs associated with specific cluster of conditions in this population.

In addition, one question still needs to be addressed; how does healthcare use impact individuals across different multimorbidity clusters? The question is also relevant, given the significance of self-rated health as a predictor of mortality, functional health and the use of healthcare services among older population. Self-rated health following healthcare use may indeed an important aspect to provide valuable information on the outcomes and effectiveness of the healthcare services provided to individual with multimorbid conditions. In this context, self-report health may hinder the complexity of their health conditions and understanding the required level of care across the multimorbidity clusters [21, 22]. Although, evidence suggests that individuals with greater numbers of chronic conditions reported lower self-rated health, highlighting the impact of multimorbidity on overall well-being [23, 24]. Assessing the impact of healthcare use on self-reported health across the multimorbidity cluster may enable a comprehensive understanding of how healthcare use affects individuals with different multimorbidity clusters. This is also important as this perspective provides valuable insight into the unique healthcare requirements of each cluster, ultimately contributing to the improvement of health outcomes and well-being, particularly among the elderly.

In light of these available pieces of evidence, there is a knowledge gap to understand the epidemiology of multimorbidity clusters that extends beyond simply counting diseases. This gap hinders the development of effective interventions to address the complex healthcare needs of the aging population in India, particularly for those living with multimorbidity. To fill this important knowledge gap in India, the current study aimed to explore multimorbidity clusters based on patterns of disease co-occurrence concerning healthcare use and self-rated health. The conceptual framework of this study was depicted in Fig 1. The framework also employs covariates for two purposes: firstly, for controlling potential confounding factors, and secondly, for estimating propensity scores to address selection biases. Based on the rationale outlined above, the following research questions were addressed in this study:

Fig 1. Conceptual framework of the study.

Fig 1

  1. What are the distinct clusters of chronic diseases co-occurrence among Indian older population.

  2. How do different multimorbidity clusters influence healthcare use among older population?

  3. How does healthcare use impact self-rated health among older individuals with different multimorbidity clusters?

Material & methods

Data source and study sample

This study was based on cross-sectional data from the first wave of the Longitudinal Aging Study in India conducted in 2017–18. LASI is a large nationally representative survey covering people aged 45 and above in India and part of a global family of longitudinal health and aging studies in more than 30 countries. The prime objective of the LASI survey is to provide information on the health, economic, social, and psychological behaviors of older adults in India and its states and union territories. In the first wave, LASI adopted a multistage stratified area probability cluster sampling design. A total participant of 72,250 individuals aged ≥45 years and their spouses (irrespective of age) from all states (except Sikkim) and Union Territories (UTs) were included in the survey. Separately written informed consent was obtained for household and individual surveys and dried blood spot collection. The ethical guidelines for data collection in LASI were approved by all collaborating institutions and the Indian Council of Medical Research (ICMR). Detailed information on ethical protocols, survey design, and sampling procedure data collection is available in the LASI India report [25]. In the present study, we included 31,464 people aged 60 years or more.

Measures

Healthcare use

Information regarding the healthcare use from any medical facilities or medical providers was collected based on the following question: “In the past 12 months, have you visited any healthcare facility or any health professional visited you?”. Healthcare providers were public facilities (e.g., Primary, Urban, Community health centers, District, Government/tertiary hospitals, etc.,) and private facilities (e.g., Private hospital/nursing home, non-governmental organization (NGO)/Charity/Trust/Church-run hospital, etc). Based on the above responses, we constructed a binary variable for healthcare use and were coded as 1 “Yes” if respondents have visited any of the above healthcare facilities and 0 “No” if they have not visited any healthcare facilities.

Chronic health conditions

A total of 19 chronic diseases were included as indicators of multimorbidity in the study population from responses to the question: “Has any health professional ever diagnosed you with the following chronic conditions or diseases?”. There is a list of nineteen self-reported chronic diseases included in this study. These are hypertension, chronic heart diseases (CHD), chronic obstructive pulmonary disease (COPD), stroke, chronic bronchitis, asthma, diabetes, cancer or malignant tumor, arthritis, rheumatism, osteoporosis, mental disorders, thyroid disease, urinary incontinence, gastrointestinal disorders, skin disease, chronic renal failure, kidney stones, and high cholesterol. Based on presence or absence, the above-diagnosed diseases were coded as 1 “Yes” and 0 “No” and further a list of chronic conditions was used in Latent Class Analysis to be grouped into clusters. Clusters with two or more conditions were defined as multimorbidity clusters [26].

Self-rated health (SRH)

In epidemiological research, self-rating of health is among the most frequently assessed health perceptions and has been considered the strongest predictor of future morbidity and mortality [27]. Therefore, SRH was defined by using a single question “Overall, how is your health in general?” with five response categories such as 1 “Very poor”, 2 “Poor”, 3 “Fair”, 4 “Good”, and 5 “Very Good”. The higher score indicates a higher level of SRH of an individual’s perceived health.

Covariates

Several potential covariates were selected from the survey including demographic and socioeconomic factors. The covariates used for this study from the LASI survey are described in Table 1.

Table 1. Description of the covariates from the LASI survey, 2017–18.

Covariates Category
Place of residence Rural
Urban
Age group 60-69 years
70-79 years
80 years or more
Wealth status 1 Poorest
Poor
Middle
Richer
Richest
Religion Hindu
Muslim
Other (Sikh, Christian, and others)
Social groups 2 Scheduled caste (SC)
Scheduled tribe (ST)
Other backward class (OBC)
Other
Gender Male
Female
Education No education
Less than 5 years
5-9 years
10 or more years
Marital status In union
Not in union
Living alone No
Yes
Region North
Central
East
North East
West
South

1Information on the wealth status of the respondents was determined using the monthly per capita expenditure (MPCE) of the households

2Social group like SC, ST & OBC are legally designated groupings of individuals among India’s most disadvantaged socioeconomic groups experiencing stigma, limited access to education, lower asset holding, and reduced access to health and healthcare.

Statistical analysis

Of the 31,464 individuals aged 60 years or more who responded to the survey, 91 had missing data on at least one study variable. After excluding missing data from the database, resulting in a final sample of 31,373 individuals aged 60 years or more (Fig 2). Initially, descriptive statistics of the study variables and chronic health conditions were presented.

Fig 2. Flow chart of the sample selection process.

Fig 2

Identification of multimorbidity clusters (Latent class model)

Furthermore, Latent class analysis (LCA) was utilized to identify multimorbidity clusters. The main purpose of this analysis was to determine whether healthcare use varies across different multimorbidity clusters. Adjusted Bayesian Information Criteria (BIC) and the consistent Akaike Information Criteria (CAIC) were considered to determine the optimal number of latent classes [28]. The likelihood-ratio G2 statistic (and parametric bootstrap likelihood ratio test) were used to test the null hypothesis that the specified LCA model fits the data (i.e., a significant p-value indicated that the null model was too restrictive) [29]. The adjusted BIC and CAIC are more robust indicators of class enumeration with categorical outcomes and were used to compare several plausible models where the lowest values indicate the best-fitting model [30]. After the selection of an optimal model, interpretability and clinical judgment were required, therefore, item-response probabilities (i.e., the estimated probability of reporting a particular NCD, given membership in particular latent class) were utilized to assign labels to the identified latent disease classes, i.e., the labels were based on the item(s) (disease(s)) with higher probabilities [18, 31]. Item-response probabilities of 30% or higher were deemed to be the optimal fit following suggestions from existing research [32]. Therefore, each respondent was assigned to their best-fit class based on the maximum item-response probability of each latent class calculated as an indicator of classification certainty. Finally, an independent variable containing identified multimorbidity clusters was created.

Examination of the associations between multimorbidity clusters and healthcare use (logistic regression model)

Binary logistics regression models were fitted to examine univariate (odds ratios [ORs]) and adjusted associations (adjusted odds ratios [aORs]) between identified multimorbidity clusters and the outcome of healthcare use. We also estimated 95% confidence intervals (95% CI). The equation of the logistic regression, considering healthcare use as the outcome variable (y) were as follows:

Crude model:

logit(y)=ln(p1−p)=β0+β1X1

Adjusted model:

logit(y)=ln(p1−p)=β0+β1X1+β2X2+β3X3+⋯+βkXk

The crude model consists of the intercept term (β₀) and the regression coefficient (β₁) for the primary independent variable of interest which was the multimorbidity cluster (X1). The adjusted model extends the crude model by including additional independent variables (X2, X3,…..Xk) as covariates that are sociodemographic variables. Each covariate has its regression coefficient (β₂, β₃,…, βₖ). This allows for examining the adjusted associations between healthcare use and the multimorbidity cluster while controlling for the effects of sociodemographic variables included as covariates.

Investigation of the impact of healthcare use on the level of SRH within each multimorbidity cluster (propensity model)

In this section of the study, we focused on five different subgroups based on identified multimorbidity clusters. For each cluster, we employed the propensity score matching (PSM) method to investigate how healthcare utilization affects the level of SRH among older people. Healthcare use was considered as a treatment variable and SRH as an outcome variable. Firstly, a logistic regression model stratified by each subsample (cluster) was used to estimate all participants’ propensity scores for healthcare use based on the selected study covariates. Secondly, estimated propensity scores were used to match the study subsample using the nearest neighbours matching algorithm. It can evaluate the balance after propensity score matching in which the treatment group is ‘participants using healthcare’ and the control is ‘participants not using healthcare. The formula is given below:

Di=Y1i−Y0i

Where Di is the difference between outcome (SRH) for an ith individual with treatment (healthcare use) and without treatment (no healthcare use) and (Y1i, Y0i) demonstrates the SRH if an ith individual uses healthcare or does not use healthcare. It is also known as the treatment effect (causal effect of the treatment). Alternatively, we estimated the average treatment effect (ATE) and average treatment effect on treated (ATET). The formula for these two estimates follows:

ATE=E(Di)=E(Y1−Y0)=E(Y1)−E(Y0)

Where E (Y1) is the expected value of Y for all the units in the treatment group and E(Y0) is the expected value of Y for all the units in the control group.

ATET=E(Y1−Y0|T=1)=E(Y1|T=1)−E(Y0|T=0)

In the above equation, T = (0,1) refers to the control and treatment groups. ATET is the difference in average actual outcomes between treatment and control groups. However, E(Y0|T = 1) refers to a contrafactual mean for those being not treated is not observed.

Sample survey weights were used in the analysis. Statistical analysis was done in Stata version 17.0 and the significance level was set at a two-sided p-value of 0.05 [33].

Ethics approval

The study was performed as per the Helsinki Declaration and the national and international guidelines. The necessary guidance and ethical guidelines in the LASI survey were approved by the Indian Council of Medical Research (ICMR), India. More details on the guidelines and protocols are available in the LASI India report.

Results

Sample characteristics and morbidity conditions among older people in India

Nearly two-thirds of the respondents were from rural areas; almost 82% were Hindus and 12% were Muslims. In the study sample, more than half of the respondents are older women (52.80%). Almost 57% of respondents had no education whereas nearly 22% had more than ten years of education. Nearly 38% of respondents were not in a union and about 6% were living alone (see Table 2). The most common chronic conditions were hypertension (32.78%), gastrointestinal disorders (19.10%), and diabetes (14.25%). Other common chronic conditions were arthritis (10.97%), and rheumatism (7.86%), skin diseases (5.24%) (see Fig 3).

Table 2. Socio-demographic profile of the study participants for older people in India, 2017–18.

Sample Characteristics N %
Place of residence
Rural 20,682 70.87
Urban 10,691 29.13
Age group
60–69 years 18,926 58.73
70–79 years 9,072 29.94
80 years or more 3,375 11.33
Wealth status *
Poorest 6,462 21.79
Poor 6,456 21.78
Middle 6,397 20.63
Richer 6,157 19.29
Richest 5,901 16.51
Religion
Hindu 23,040 82.66
Muslim 3,720 10.94
Other 4,612 6.41
Social groups
SC 5,127 18.98
ST 5,159 8.15
OBC 11,850 45.02
Others 9,237 27.86
Gender
Male 15,036 47.20
Female 16,337 52.80
Education
No Education 16,853 56.76
Less than 5 years 3,772 11.48
5–9 Years 5,997 17.89
10 or more years 4,751 13.86
Marital status
In Union 20,032 61.92
Not in Union 11,341 38.08
Living alone
No 29,756 94.39
Yes 1,617 5.71
Region
North 5,799 12.65
Central 4,259 21.07
East 5,749 23.76
Northeast 3,739 2.97
West 4,282 17.21
South 7,545 22.34
Total 31,373 100.0

SC: Scheduled caste; ST: Scheduled tribe; OBC: Other backward class

N: Frequency; %: Percentages; Frequencies are unweighted; Percentages are weighted.

* Wealth status was based on monthly per capita expenditure (MPCE)

Fig 3. Prevalence of chronic health condition among older people in India, 2017–18.

Fig 3

Multimorbidity clusters among older people in India

Fig 4 shows the value of adjusted BIC and CAIC for the one to five-class LCA models for older people. There was a considerable decline in the adjusted BIC and CAIC values from the two-class to the five-class model and the above five-class models were not well-identified indicating the five-class model is the optimum. Fig 5 presents the item-response probabilities for the five-class model for older people. Based on the item-response probabilities, we found five multimorbid clusters and they have been assigned descriptive labels to characterize their comorbid characteristics. Age and sex-adjusted prevalence of each cluster were given in Fig 6. Class 1 was labelled as “relatively healthy” as it was characterized by individuals with low probabilities of all 19 chronic conditions and the majority of the study sample (68.37%) were classified as being in this “relatively healthy” class. Class 2 was labelled as a ‘metabolic disorder’ as it was classified by individuals with a high probability of hypertension and diabetes and it comprised 16.48% of study sample. Class 3 was labelled as ‘hypertension/gastrointestinal/musculoskeletal’ as it included those with a high probability of hypertension, and gastrointestinal, and musculoskeletal disorders and comprised 9.04% of the study sample. Class 4 was labelled as ‘hypertension/musculoskeletal’ as it was characterized by an increased probability of hypertension and musculoskeletal disorder. A remaining pattern which is in Class 5 was labelled as ‘complex multimorbidity’ as it included ≥3 health conditions and comprised 1.94% of study sample.

Fig 4. Relative fit for latent class analysis (cAIC, adjusted BIC).

Fig 4

Fig 5. Probabilities of having chronic conditions for each latent class for older people in India, 2017–18.

Fig 5

Fig 6. Age and sex adjusted prevalence od identified multimorbid clusters among older people in India, 2017–18.

Fig 6

Association between multimorbidity clusters and healthcare use among older people

Table 3 illustrates the to examine the association between identified multimorbidity clusters and healthcare use among older people. Older people with ‘Complex multimorbidity’ cluster (94.35%) reported higher healthcare use, followed by ‘hypertension/gastrointestinal’ cluster (89.69%), ‘hypertension/gastrointestinal/musculoskeletal’ cluster (89.51%) and ‘metabolic disorders’ cluster (87.06%). Results from binary logistic regression analysis showed that compared with the ‘relatively healthy’ cluster, healthcare use was significantly higher for each multimorbidity cluster even after controlling potential covariates. The odds ratio for the “complex multimorbidity” cluster in both the crude and adjusted model was relatively higher ([OR:7.05, 95% CI: 3.81–13.02] and [aOR:7.03, 95% CI: 3.54–13.96], respectively) followed by ‘hypertension/gastrointestinal/musculoskeletal’ cluster ([OR:3.60, 95% CI: 3.03–4.29] and [aOR:3.27, 95% CI: 2.74–3.91], respectively), ‘hypertension/gastrointestinal’ cluster ([OR:3.67, 95% CI: 2.90–4.66] and [aOR:3.01, 95% CI: 2.35–3.82], respectively) and ‘metabolic disorders’ cluster ([OR: 2.84, 95% CI: 2.33–3.46] and [aOR: 2.78, 95% CI: 2.29–3.38], respectively).

Table 3. Association between multimorbidity clusters and healthcare use for older people in India, 2017–18.

Latent class Multimorbidity cluster Healthcare use (%)* Crude model Adjusted model
OR [95% CI] OR [95% CI]
Class 1 Relatively Healthy (Ref.) 70.31 1 1
Class 2 Metabolic disorder 87.06 2.84* [2.33–3.46] 2.78* [2.29–3.38]
Class 3 Hypertension/Gastrointestinal/musculoskeletal 89.51 3.60* [3.03–4.29] 3.27* [2.74–3.91]
Class 4 Hypertension/Gastrointestinal 89.69 3.67* [2.90–4.66] 3.01* [2.35–3.82]
Class 5 Complex multimorbidity 94.35 7.05* [3.81–13.02] 7.03* [3.54–13.96]

* Significant using chi-square test; OR: odds ratio estimated from logistic regression; 95% CI: 95% Confidence intervals; Ref: Reference category; *p<0.05

All models were adjusted for sociodemographic variables including gender, education, marital status, place of residence, wealth status

religion, caste, and region.

Impact of health care use on the level of SRH within each multimorbidity cluster among older people in India

First, the estimated ATT of healthcare use on SRH for each cluster was presented in Table 4. Using the nearest neighbor matching method demonstrated that healthcare use was significantly associated with a decline in SRH in each multimorbidity cluster. In the ‘complex multimorbidity’ cluster, there is a significant decline in the level of SRH (i.e., ATT = -0.4324, T-value = -1.94) followed by the ‘hypertension/gastrointestinal’ cluster (ATT = -0.4148, T-value = -3.36), ‘hypertension/gastrointestinal/musculoskeletal’ cluster (ATT = -0.3778, T-value = -5.14), and ‘metabolic disorders’ cluster (ATT = -0.3553, T-value = -6.64). Alternatively, similar results in Table 5 were shown by the coefficient of ATE and ATET which means that across multimorbidity clusters, even after using healthcare, the level of SRH is declined. For the ‘complex multimorbidity’ clusters, the value of ATE and ATET was -0.5643 (p-value<0.05) and -0.5954 (p-value<0.05), respectively, signified that healthcare use decreased the level of SRH by 56.43% and the propensity score for a high level of SRH was 59.54% points lower among those used healthcare.

Table 4. Results from PSM for the role of healthcare use on the SRH in subsamples stratified by multimorbidity clusters for older people in India, 2017–18.

Latent class  Subsamples stratified by
Multimorbidity clusters
Treatment Outcome: SRH
Treated Control Difference S.E. T-value
Class 1 Relatively Healthy Healthcare use 2.61 2.99 -0.38 0.02 -23.84*
Class 2 Metabolic disorder Healthcare use 2.34 2.70 -0.36 0.05 -6.64*
Class 3 Hypertension/Gastrointestinal/musculoskeletal Healthcare use 2.24 2.62 -0.38 0.07 -5.14*
Class 4 Hypertension/Gastrointestinal Healthcare use 2.10 2.52 -0.41 0.12 -3.36*
Class 5 Complex multimorbidity Healthcare use 1.81 2.24 -0.43 0.22 -1.94*

Note-Each latent class or cluster is presented as a subsample; S.E: Standard error

*p<0.05

Table 5. Estimated ATE and ATET of healthcare use on the level of SRH across identified multimorbidity clusters for older people in India, 2017–18.

Latent class Subsamples stratified by
Multimorbidity clusters
ATE ATET
Coefficient [95% CI] Robust S.E. Coefficient [95% CI] Robust S.E.
Class 1 Relatively Healthy -0.37* [-0.41 to -0.34] 0.02 -0.38* [-0.42 to -0.35] 0.02
Class 2 Metabolic disorder -0.37* [-0.46 to -0.29] 0.05 -0.37* [-0.47 to -0.28] 0.05
Class 3 Hypertension/Gastrointestinal/musculoskeletal -0.48* [-0.61 to -0.36] 0.06 -0.48* [-0.61 to -0.35] 0.07
Class 4 Hypertension/Gastrointestinal -0.40* [-0.77 to -0.04] 0.18 -0.41* [-0.78 to -0.03] 0.19
Class 5 Complex multimorbidity -0.56* [-0.78 to -0.35] 0.11 -0.60* [-0.82 to -0.37] 0.11

ATE: Average treatment effect; ATET: Average treatment effect on the treated; 95% CI: 95% Confidence intervals; S.E.: Standard error

*p<0.05.

Discussion

The present study examined multimorbidity clusters in older people, healthcare utilization across these clusters, and the impact of healthcare use on their self-rated health. A nationally representative dataset of 31,373 individuals aged 60 years or more was thoroughly analyzed, incorporating information on 19 chronic conditions. The study identified five distinct multimorbidity clusters with prevalence rates adjusted for age and sex: ‘relatively healthy’ (68.72%), ‘metabolic disorder’ (16.26%), ‘hypertension-gastrointestinal-musculoskeletal’ (9.02%), ‘hypertension-gastrointestinal’ (4.07%), and ‘complex multimorbidity’ (1.92%). Additionally, our study observed variations in the strength of the association between multimorbidity clusters and healthcare use in older people, and the association was stronger for people with cluster hypertension-gastrointestinal-musculoskeletal and complex multimorbidity. Surprisingly, results from the PSM analysis indicated that healthcare use did not lead to an improvement in perceived health status among older individuals with identified multimorbidity clusters.

Among the identified clusters, the relatively healthy cluster is consistent with the previous studies reporting a similar latent class representing the majority of the study sample, ranging from 50 to 70 percent [17, 34–37]. The second most prevalent cluster, the metabolic disorders cluster, comprising comorbidity of hypertension and diabetes, is also supported by previous studies [17, 37]. We speculated that this cluster may be caused by increased risk factors for both diabetes and hypertension such as obesity (or an unbalanced diet rich in fat and salt, for example), excessive carbohydrate and alcohol intake prevalent in the Indian population [38–40]. Moreover, there has been a well-described association between diabetes and hypertension by sharing common metabolic abnormalities and pathophysiology [41, 42]. The third identified cluster hypertension-gastrointestinal may be due to the impact of metabolism-related risk factors on the gastrointestinal tract, a crucial organ in metabolic syndrome and metabolic hypertension (i.e., hypertension due to metabolic disturbance Studies have indicated that the gastrointestinal tract plays a significant role in both metabolic syndrome and hypertension, explaining the clustering of gastrointestinal disorders and hypertension among older individuals in India [43, 44]. Furthermore, medications used for musculoskeletal disorders, such as non-steroidal anti-inflammatory drugs for arthritis, can have a strong adverse effect on gastrointestinal-related organs like the stomach [45]. This could increase the risk of stomach or digestive disorders in individuals with musculoskeletal conditions, potentially contributing to the identification of the fourth cluster of hypertension-gastrointestinal-musculoskeletal in the current study. Noteworthy, hypertension stood out as the prevalent health condition among those with existing chronic conditions, suggesting that individuals diagnosed with hypertension could be grouped with other chronic diseases, heightening the risk of health complications.

Limited studies explored healthcare use in different combinations of chronic diseases, reporting variations across multimorbidity clusters, but no such study exists for India [18–20]. Our research aligns with this trend and further reveals that the identified multimorbidity clusters differ in the extent of their healthcare usage. For instance, older people belonging to the complex multimorbidity cluster, followed by the hypertension-gastrointestinal-musculoskeletal cluster, were more likely to use healthcare services than individuals with relatively healthy cluster. It is speculated that multimorbidity clusters involving three or more conditions affecting at least three different organ systems in one person may require regular care and higher inpatient services for assessing their health status and implementing secondary prevention [46]. This is reinforced by a previous study, which reported that older people in India with three or more conditions were 1.5 times more likely to utilize healthcare, including both inpatient and outpatient care [8]. Furthermore, studies have indicated that age-related musculoskeletal disorders, such as arthritis, are associated with increased functional disability and a higher probability of seeking medical attention, undergoing outpatient surgeries, experiencing hospitalization events, and requiring more ambulatory care [47–49]. Moreover, when combined with other health conditions like hypertension and gastrointestinal disorders, the situation becomes more complex, potentially increasing the demand for medical care. This finding suggests that Indian healthcare systems and providers need to be prepared to handle the growing complexity and demand for integrated, multidisciplinary care.

Our findings also add depth to the understanding of the interplay between healthcare utilization and individuals’ perception of their health within each multimorbidity cluster. The findings are also interesting in the context that, it is usually assumed that using health care not only improves an individual’s physical health but also helps to improve overall well-being [50]. Contrary to this common assumption, our results indicate that higher outpatient and inpatient healthcare use with multimorbidity does not necessarily result in an improvement in their subjective perception of their health [51, 52]. It may be speculated that the association between healthcare utilization and perceived health is influenced by various factors beyond the mere utilization of healthcare services. Various aspects such as the nature and severity of chronic conditions, psychological factors, social support, and quality of care received may also play significant roles in shaping individuals’ perception of their health [24, 53–56]. This finding also shows the lack of communication and dialogue between patients with the healthcare system in India. It is important to mention that, in many developed countries where therapies and community meetings are common for patients suffering certain morbidity or life-threatening diseases, there is no such concept in the Indian context [57]. This finding also shows the urgency of the inclusion of counselling and therapies for addressing well-being.

Strength and limitations

Major strengths of the present study include the provision of a large and nationally representative sample of the older population which could be generalized to the whole country. Furthermore, this research employed a comprehensive list of nineteen chronic diseases and followed a universally accepted definition of "multimorbidity," which refers to the simultaneous presence of two or more chronic diseases. More importantly, examining possible clusters of chronic health conditions in relation to healthcare utilization and perceived health may help for improving clinical protocols and promote health and well-being. To achieve this, the research employed a widely adopted technique (LCA), which has been utilized in recent years and served as the foundation for other multimorbidity pattern studies [31, 32, 34, 36]. To do so, it applies a technique (LCA) that has been widely used in recent years and has been the basis for other studies of multimorbidity patterns.

Some limitations should be considered when interpreting the findings of the present study. Firstly, the use of self-reported measures of chronic disease and healthcare utilization may have underestimated their prevalence, especially among older individuals and those from poorer socioeconomic and educational backgrounds, who are more inclined to underreport these characteristics. Secondly, the cross-sectional nature of data limits us from inferring confident causal conclusions. Thirdly, the number of latent classes and clusters/patterns may not be comparable due to the result of variations in the characteristics of the study sample as well as the number and type of chronic diseases that were examined. Beyond the statistical technique, our investigation found some clusters that were expected and corroborated by the results of other studies carried out in India and other nations [34, 58, 59]. Fourthly, we also include participants without chronic disease or multimorbidity for comparison purposes in the context of healthcare use, which may explain the contrasting findings. Fifthly, the study lacked data on the timing of diagnoses and the severity of the conditions. Future research that includes such information in the analysis could offer valuable insights for developing more effective prevention strategies. Lastly, we could only focus on physical chronic health conditions, and the inclusion of mental health conditions in future studies may reveal different patterns and provide a more comprehensive perspective.

Implication for practice and research

The present study indicates hypertension as a common chronic condition to be clustered with other health conditions among Indian older people. Hypertension, a manageable but often not curable, affects the cardiovascular system leading to cardiac complications and other health conditions, particularly in later life [60]. Therefore, Indian physicians should focus on lowering blood pressure by considering a comprehensive assessment of the patient’s medical history and lifestyle to tailor personalized treatment plans [61]. In this context, there is a need to strengthen the implementation of high-impact and low-cost programs to diagnose and control elevated blood pressure, ensuring its comprehensive coverage to the whole country, with a particular focus on the older population [62].

Moreover, findings from this study indicate the variation in the magnitude of the association between healthcare use and different multimorbid cluster. It highlights the need for unique and a patient-centric approach in primary care settings to treat patients with multiple chronic conditions. Evidence suggested that the Indian healthcare system which is a single-disease paradigm primarily focused on acute care may not be adequate in the treatment of older people, particularly those living with multiple conditions [63]. Therefore, there is a need for more effective and patient-centric healthcare to tackle the complex interactions of chronic diseases or specific combinations of diseases that patients may accumulate. Future research should delve deeper into understanding the interactions between chronic conditions including physical and mental health, while also examining various aspects of healthcare utilization, such as inpatient and outpatient care, polypharmacy, length of hospital inpatient stays, healthcare expenditure, and medication adherence. This holistic approach will contribute to facilitate more informed decision making and multimorbidity management.

Considering subjective health following healthcare use, our study offers valuable insights into the complexity of multimorbid conditions and the effectiveness of healthcare use. This underscores the importance of urgently integrating counseling and therapies focused on addressing well-being into the treatment plans for patients with multimorbidity. A further longitudinal epidemiological study is needed to provide a more comprehensive understanding of how healthcare utilization and disease interactions impact older individuals’ health and well-being in the Indian population.

Conclusion

This study sheds light on the complexity of multimorbidity among older individuals in India, identifying five distinct clusters of chronic health conditions with differing healthcare utilization patterns. The findings underscore the significance of considering interactions between conditions, which can complicate decision-making and management strategies. Moreover, the study highlights that healthcare use is influenced by specific combinations of health conditions rather than just their quantity. Indian healthcare system which is very largely configured for acute care services and predominantly guided by single-disease pathways is not sufficient to deal with patients suffering from different combinations of diseases. Our findings support the creation of clinical practice guidelines (CPGs) focusing on a patient-centric approach to optimize multimorbidity management in older people. The noteworthy finding from the current research is that healthcare utilization did not lead to a significant improvement in the reported health statuses of older individuals. This finding shows the urgency of the inclusion of counseling and therapies for addressing well-being when treating patients with multimorbidity.

Data Availability

The datasets generated and/or analyzed during the current study are available in the International Institute for Population Sciences (IIPS), Mumbai repository. A reasonable request for data access can be made at https://www.iipsindia.ac.in/content/LASI-data.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Moffat K, Mercer SW. Challenges of managing people with multimorbidity in today’s healthcare systems. BMC Fam Pract. 2015. Dec;16(1):129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.United Nations Population Fund. caring for our Elders: Early Response”—India Aging Report—2017. New Delhi India: UNFPA. 2017; [Google Scholar]
  • 3.Ansari S, Muhammad T, Dhar M. How Does Multi-Morbidity Relate to Feeling of Loneliness among Older Adults? Evidence from a Population-Based Survey in India. J Popul Ageing [Internet]. 2021. Aug 3 [cited 2022 Nov 13]; Available from: https://link.springer.com/10.1007/s12062-021-09343-5 [Google Scholar]
  • 4.Ansari S, Anand A, Hossain B. Multimorbidity and depression among older adults in India: Mediating role of functional and behavioural health. Pegoraro C, editor. PLOS ONE. 2022. Jun 7;17(6):e0269646. doi: 10.1371/journal.pone.0269646 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Muhammad T, Pai M, Ansari S. Gender differences in the association between cardiovascular diseases and major depressive disorder among older adults in India. Dialogues Health. 2023. Dec;2:100107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Arokiasamy P, Uttamacharya, Jain K. Multi-Morbidity, Functional Limitations, and Self-Rated Health Among Older Adults in India: Cross-Sectional Analysis of LASI Pilot Survey, 2010. SAGE Open. 2015 Mar 1;5(1):215824401557164. [Google Scholar]
  • 7.Ansari S, Anand A, Singh S, Hossain B. Exploring food insecurity and multimorbidity in Indian socially disadvantaged people: cross-sectional findings from LASI, 2017–18. BMC Public Health. 2023. Jun 26;23(1):1234. doi: 10.1186/s12889-023-16132-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Pati S, Agrawal S, Swain S, Lee JT, Vellakkal S, Hussain MA, et al. Non communicable disease multimorbidity and associated health care utilization and expenditures in India: Cross-sectional study. BMC Health Serv Res. 2014;14(1):1–9. doi: 10.1186/1472-6963-14-451 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Pati S, Swain S, Hussain MA, Kadam S, Salisbury C. Prevalence, correlates, and outcomes of multimorbidity among patients attending primary care in Odisha, India. Ann Fam Med. 2015. Sep;13(5):446–50. doi: 10.1370/afm.1843 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Pati S, Swain S, Knottnerus JA, Metsemakers JFM, Van Den Akker M. Magnitude and determinants of multimorbidity and health care utilization among patients attending public versus private primary care: A cross-sectional study from Odisha, India. Int J Equity Health. 2020;19(1):1–12. doi: 10.1186/s12939-020-01170-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Pati S, Mahapatra P, Dwivedi R, Athe R, Sahoo KC, Samal M, et al. Multimorbidity and Its Outcomes Among Patients Attending Psychiatric Care Settings: An Observational Study From Odisha, India. Front Public Health. 2021. Apr 21;8:616480. doi: 10.3389/fpubh.2020.616480 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Puri P, Pati S. Exploring the Linkages Between Non-Communicable Disease Multimorbidity, Health Care Utilization and Expenditure Among Aboriginal Older Adult Population in India. Int J Public Health. 2022. Mar 7;67:1604333. doi: 10.3389/ijph.2022.1604333 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Fortin M, Stewart M, Poitras ME, Almirall J, Maddocks H. A Systematic Review of Prevalence Studies on Multimorbidity: Toward a More Uniform Methodology. Ann Fam Med. 2012. Mar 1;10(2):142–51. doi: 10.1370/afm.1337 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Academy of medical sciences (Royaume uni). Multimorbidity: a priority for global health research. Academy of medical sciences; 2018. [Google Scholar]
  • 15.Pati S, Swain S, Metsemakers J, Knottnerus JA, van den Akker M. Pattern and severity of multimorbidity among patients attending primary care settings in Odisha, India. Lee A, editor. PLOS ONE. 2017. Sep 14;12(9):e0183966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kshatri JS, Palo SK, Bhoi T, Barik SR, Pati S. Prevalence and Patterns of Multimorbidity Among Rural Elderly: Findings of the AHSETS Study. Front Public Health. 2020. Nov 5;8:582663. doi: 10.3389/fpubh.2020.582663 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Puri P, Singh SK, Pati S. Identifying non-communicable disease multimorbidity patterns and associated factors: a latent class analysis approach. BMJ Open. 2022. Jul;12(7):e053981. doi: 10.1136/bmjopen-2021-053981 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Larsen FB, Pedersen MH, Friis K, Glümer C, Lasgaard M. A Latent Class Analysis of Multimorbidity and the Relationship to Socio-Demographic Factors and Health-Related Quality of Life. A National Population-Based Study of 162,283 Danish Adults. Boltze J, editor. PLOS ONE. 2017. Jan 5;12(1):e0169426. doi: 10.1371/journal.pone.0169426 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Dong HJ, Wressle E, Marcusson J. Multimorbidity patterns of and use of health services by Swedish 85-year-olds: an exploratory study. BMC Geriatr. 2013. Dec;13(1):120. doi: 10.1186/1471-2318-13-120 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Zhao X, Zhang Q, Ma C, Liu H, Chen Y. Association between multimorbidity patterns and healthcare costs among middle-aged and older adults in China. Arch Gerontol Geriatr. 2023. Jun;109:104959. doi: 10.1016/j.archger.2023.104959 [DOI] [PubMed] [Google Scholar]
  • 21.Elston J, Gradinger F, Asthana S, Lilley-Woolnough C, Wroe S, Harman H, et al. Does a social prescribing ‘holistic’ link-worker for older people with complex, multimorbidity improve well-being and frailty and reduce health and social care use and costs? A 12-month before-and-after evaluation. Prim Health Care Res Dev. 2019;20:e135. doi: 10.1017/S1463423619000598 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Cislaghi B, Cislaghi C. Self-rated health as a valid indicator for health-equity analyses: evidence from the Italian health interview survey. BMC Public Health. 2019. Dec;19(1):533. doi: 10.1186/s12889-019-6839-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Francis ME, Pennebaker JW. Putting Stress into Words: The Impact of Writing on Physiological, Absentee, and Self-Reported Emotional Well-Being Measures. Am J Health Promot. 1992. Mar 1;6(4):280–7. doi: 10.4278/0890-1171-6.4.280 [DOI] [PubMed] [Google Scholar]
  • 24.Akhtar SN, Saikia N, Muhammad T. Self-rated health among older adults in India: Gender specific findings from National Sample Survey. Navaneetham K, editor. PLOS ONE. 2023. Apr 17;18(4):e0284321. doi: 10.1371/journal.pone.0284321 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.International Institute for Population Sciences (IIPS). Longitudinal Ageing Study in India (LASI) Wave 1. 2020; Available from: https://www.iipsindia.ac.in/sites/default/files/LASI_India_Report_2020_compressed.pdf
  • 26.Fortin M, Stewart M, Poitras ME, Almirall J, Maddocks H. A Systematic Review of Prevalence Studies on Multimorbidity: Toward a More Uniform Methodology. Ann Fam Med. 2012. Mar 1;10(2):142–51. doi: 10.1370/afm.1337 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Mossey JM, Shapiro E. Self-rated health: a predictor of mortality among the elderly. Am J Public Health. 1982. Aug;72(8):800–8. doi: 10.2105/ajph.72.8.800 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Schwarz G. Estimating the Dimension of a Model. Ann Stat. 1978;6(2):461–4. [Google Scholar]
  • 29.Lanza ST, Rhoades BL. Latent Class Analysis: An Alternative Perspective on Subgroup Analysis in Prevention and Treatment. Prev Sci. 2013. Apr;14(2):157–68. doi: 10.1007/s11121-011-0201-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Nylund KL, Asparouhov T, Muthén BO. Deciding on the Number of Classes in Latent Class Analysis and Growth Mixture Modeling: A Monte Carlo Simulation Study. Struct Equ Model Multidiscip J. 2007. Oct 23;14(4):535–69. [Google Scholar]
  • 31.Park B, Lee HA, Park H. Use of latent class analysis to identify multimorbidity patterns and associated factors in Korean adults aged 50 years and older. Latham-Mintus K, editor. PLOS ONE. 2019. Nov 13;14(11):e0216259. doi: 10.1371/journal.pone.0216259 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Craig LS, Hotchkiss DR, Theall KP, Cunningham-Myrie C, Hernandez JH, Gustat J. Prevalence and patterns of multimorbidity in the Jamaican population: A comparative analysis of latent variable models. Thet Wai K, editor. PLOS ONE. 2020. Jul 23;15(7):e0236034. doi: 10.1371/journal.pone.0236034 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.StataCorp. Stata Statistical Software: Release 17. College Station, TX: StataCorp LLC.; 2021. [Google Scholar]
  • 34.Olaya B, Moneta MV, Caballero FF, Tyrovolas S, Bayes I, Ayuso-Mateos JL, et al. Latent class analysis of multimorbidity patterns and associated outcomes in Spanish older adults: a prospective cohort study. BMC Geriatr. 2017. Dec;17(1):186. doi: 10.1186/s12877-017-0586-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Ho HE, Yeh CJ, Wei JCC, Chu WM, Lee MC. Trends of Multimorbidity Patterns over 16 Years in Older Taiwanese People and Their Relationship to Mortality. Int J Environ Res Public Health. 2022. Mar 11;19(6):3317. doi: 10.3390/ijerph19063317 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Whitson HE, Johnson KS, Sloane R, Cigolle CT, Pieper CF, Landerman L, et al. Identifying Patterns of Multimorbidity in Older Americans: Application of Latent Class Analysis. J Am Geriatr Soc. 2016. Aug;64(8):1668–73. doi: 10.1111/jgs.14201 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Zhang Q, Han X, Zhao X, Wang Y. Multimorbidity patterns and associated factors in older Chinese: results from the China health and retirement longitudinal study. BMC Geriatr. 2022. Dec;22(1):470. doi: 10.1186/s12877-022-03154-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Zhang X, Padhi A, Wei T, Xiong S, Yu J, Ye P, et al. Community prevalence and dyad disease pattern of multimorbidity in China and India: a systematic review. BMJ Glob Health. 2022. Sep;7(9):e008880. doi: 10.1136/bmjgh-2022-008880 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Violan C, Foguet-Boreu Q, Flores-Mateo G, Salisbury C, Blom J, Freitag M, et al. Prevalence, Determinants and Patterns of Multimorbidity in Primary Care: A Systematic Review of Observational Studies. Scuteri A, editor. PLoS ONE. 2014. Jul 21;9(7):e102149. doi: 10.1371/journal.pone.0102149 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Ofori-Asenso R, Chin KL, Curtis AJ, Zomer E, Zoungas S, Liew D. Recent Patterns of Multimorbidity Among Older Adults in High-Income Countries. Popul Health Manag. 2019. Apr;22(2):127–37. doi: 10.1089/pop.2018.0069 [DOI] [PubMed] [Google Scholar]
  • 41.Petrie JR, Guzik TJ, Touyz RM. Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms. Can J Cardiol. 2018. May;34(5):575–84. doi: 10.1016/j.cjca.2017.12.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Hypertension and Diabetes Mellitus: Coprediction and Time Trajectories. Indian J Public Health Res Dev [Internet]. 2022. [cited 2022 Dec 30];13(3). Available from: https://medicopublication.com/index.php/ijphrd/article/view/18178 [Google Scholar]
  • 43.Whitworth JA. Blood pressure and control of cardiovascular risk. Vasc Health Risk Manag. [PMC free article] [PubMed] [Google Scholar]
  • 44.Zhu Z, Xiong S, Liu D. The Gastrointestinal Tract: an Initial Organ of Metabolic Hypertension? Cell Physiol Biochem. 2016;38(5):1681–94. doi: 10.1159/000443107 [DOI] [PubMed] [Google Scholar]
  • 45.Vitetta L, Coulson S, Linnane A, Butt H. The Gastrointestinal Microbiome and Musculoskeletal Diseases: A Beneficial Role for Probiotics and Prebiotics. Pathogens. 2013. Nov 14;2(4):606–26. doi: 10.3390/pathogens2040606 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Sinha A, Kerketta S, Ghosal S, Kanungo S, Lee JT, Pati S. Multimorbidity and Complex Multimorbidity in India: Findings from the 2017–2018 Longitudinal Ageing Study in India (LASI). Int J Environ Res Public Health. 2022. Jul 26;19(15):9091. doi: 10.3390/ijerph19159091 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.MacKay C, Canizares M, Davis AM, Badley EM. Health care utilization for musculoskeletal disorders. Arthritis Care Res. 2010. Feb 1;62(2):161–9. doi: 10.1002/acr.20064 [DOI] [PubMed] [Google Scholar]
  • 48.Dunlop DD, Manheim LM, Song J, Chang RW. Health care utilization among older adults with arthritis. Arthritis Care Res. 2003. Apr 15;49(2):164–71. doi: 10.1002/art.11003 [DOI] [PubMed] [Google Scholar]
  • 49.Salkar M, Gangan N, Yang Y. Association Between Work Absence and Health Services Utilization and Costs Among Employed Individuals With Arthritis. J Occup Environ Med [Internet]. 2020;62(6). Available from: https://journals.lww.com/joem/Fulltext/2020/06000/Association_Between_Work_Absence_and_Health.10.aspx doi: 10.1097/JOM.0000000000001836 [DOI] [PubMed] [Google Scholar]
  • 50.Pati S, Mahapatra P, Kanungo S, Uddin A, Sahoo KC. Managing Multimorbidity (Multiple Chronic Diseases) Amid COVID-19 Pandemic: A Community Based Study From Odisha, India. Front Public Health. 2021. Feb 1;8:584408. doi: 10.3389/fpubh.2020.584408 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Zhong Y, Qin G, Xi H, Cai D, Wang Y, Wang T, et al. Prevalence, patterns of multimorbidity and associations with health care utilization among middle-aged and older people in China. BMC Public Health. 2023. Mar 21;23(1):537. doi: 10.1186/s12889-023-15412-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Aoki T, Fujinuma Y, Matsushima M. Associations of primary care structures with polypharmacy and patient-reported indicators in patients with complex multimorbidity: a multicentre cross-sectional study in Japan. BMJ Open. 2022. Jan;12(1):e054348. doi: 10.1136/bmjopen-2021-054348 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Srivastava S, Chauhan S, Patel R. Socio-Economic Inequalities in the Prevalence of Poor Self-Rated Health among Older Adults in India from 2004 to 2014: A Decomposition Analysis. Ageing Int. 2021. Jun;46(2):182–99. [Google Scholar]
  • 54.Ocampo JM. Self-rated health: Importance of use in elderly adults. Colomb Médica. 2010;41. [Google Scholar]
  • 55.Nützel A, Dahlhaus A, Fuchs A, Gensichen J, König HH, Riedel-Heller S, et al. Self-rated health in multimorbid older general practice patients: a cross-sectional study in Germany. BMC Fam Pract. 2014. Dec;15(1):1. doi: 10.1186/1471-2296-15-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Sudha S, Suchindran C, Mutran EJ, Rajan SI, Sarma PS. Marital Status, Family Ties, and Self-rated Health Among Elders In South India. J Cross-Cult Gerontol. 2007. Feb 20;21(3–4):103–20. [DOI] [PubMed] [Google Scholar]
  • 57.World Health Organization. Secondary prevention of noncommunicable diseases in low-and middle-income countries through community-based and health service interventions: World Health Organization-Wellcome Trust meeting report. 2001. Aug 1; [Google Scholar]
  • 58.Ng SK, Martin SA, Adams RJ, O’Loughlin P, Wittert GA. The Effect of Multimorbidity Patterns and the Impact of Comorbid Anxiety and Depression on Primary Health Service Use: The Men Androgen Inflammation Lifestyle Environment and Stress (MAILES) Study. 14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Sibley KM, Voth J, Munce SE, Straus SE, Jaglal SB. Chronic disease and falls in community-dwelling Canadians over 65 years old: a population-based study exploring associations with number and pattern of chronic conditions. BMC Geriatr. 2014. Dec;14(1):22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Dandona L, Dandona R, Kumar GA, Shukla DK, Paul VK, Balakrishnan K, et al. Nations within a nation: variations in epidemiological transition across the states of India, 1990–2016 in the Global Burden of Disease Study. The Lancet. 2017. Dec;390(10111):2437–60. doi: 10.1016/S0140-6736(17)32804-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Hiremath JS. Current Practice of Hypertension in India: Focus on Blood Pressure Goals. J Clin Diagn Res [Internet]. 2016. [cited 2023 Aug 2]; Available from: http://jcdr.net/article_fulltext.asp?issn=0973-709x&year=2016&volume=10&issue=12&page=OC25&issn=0973-709x&id=8999 doi: 10.7860/JCDR/2016/21783.8999 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Krishna A, Pathni AK, Sharma B, Shivashankar R, Shrivastava S, Hering D. A perspective of private health care providers in the state of Madhya Pradesh on adopting key strategies of the India hypertension control initiative. J Clin Hypertens. 2020. Aug;22(8):1321–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Pati S, Sinha R, Mahapatra P. Health Communication and Inter-professional Care in Context of Multimorbidity Management: Assessment of Health Professional Curricular Focus in India. Front Commun. 2021. Jun 30;6:661930. [Google Scholar]
PLOS Glob Public Health. doi: 10.1371/journal.pgph.0002330.r001

Decision Letter 0

Collins Otieno Asweto

10 Jul 2023

PGPH-D-23-01119

Exploring multimorbidity clusters in relation to healthcare use and its impact on self-rated health among older people in India

PLOS Global Public Health

Dear Hossain,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by 10th September 2023. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Collins Otieno Asweto, PhD

Academic Editor

PLOS Global Public Health

Journal Requirements:

1. Please provide separate figure files in .tif or .eps format only and remove any figures embedded in your manuscript file. Please also ensure all files are under our size limit of 10MB.

For more information about figure files please see our guidelines:

https://journals.plos.org/globalpublichealth/s/figures 

https://journals.plos.org/globalpublichealth/s/figures#loc-file-requirement

2. We have noticed that you have uploaded Supporting Information files, but you have not included a list of legends. Please add a full list of legends for your Supporting Information files after the references list. 

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Reviewer Report

Topic

Very appropriate and reads fine.

Abstract

Background: This is lacking in the abstract. The authors should provide a sentence or two on the background.

Purpose/Aim: This is apt and reads well.

Methods: Appropriate.

Results: Adequate.

Conclusion: This was adequate.

Overall comment on the abstract: Except for the missing background, the abstract was adequate and sufficient.

Introduction

Background: This was well written and sufficiently addressed the topic under study. However, some minor corrections required:

Para 2, sentence 1: Source required.

Para 3, sentence 1: Source required.

Para 4, sentence 6: “Evidence also suggests reporting poor or good.” This is not very clear. It appears hanging. Either delete or recast.

Para 4, last sentence, line 3: “This is also important as this perspective of multimorbidity

clusters and healthcare use provides us with a new dimension of multimorbidity-

related healthcare requirements to further helps to improve the health status of the

elderly.” Replace “to” with “which”.

Problem statement: Clear and elucidates the problem well.

Materials and methods

Study sample: Line 9 – “Separate written informed consent was obtained for household and

individual surveys and dried blood spot collection.” Replace “separate” with

“separately”.

Chronic health conditions, page 6, sentence 2: “The list of nineteen self-reported chronic

diseases included hypertension, chronic heart diseases (CHD), chronic obstructive

pulmonary disease (COPD), stroke, chronic bronchitis, asthma, diabetes, cancer or

malignant tumor, arthritis, rheumatism, osteoporosis, mental disorders, thyroid

disease, urinary incontinence, gastrointestinal disorders, skin disease, chronic renal

failure, kidney stones, and high cholesterol.” This sentence reads well, but too

long. Recast into two sentences.

Statistical analysis: Adequate.

Results: Adequate.

Discussions

Adequate and reads well. However, some minor corrections required:

Page 12, para 2, sentence 3: “Accumulated evidence indicated that uncontrolled high blood

pressure plays a central role in the developing cardiovascular (i.e., heart attack,

stroke, diabetes, myocardial infarction, etc.) and non-cardiovascular outcomes (i.e.,

dementia, cancer, oral health conditions, etc.) [50–52].” Please, delete the article

“the”.

Page 13, para 2, sentence 1: “While, we have also provided an important finding on the

linkage between multimorbidity clustering, healthcare use, and SRH.” This sentence

does not read well. Consider a recast.

Conclusion

This is adequate and reads well.

Overall observation

On the whole, this paper was well written. The authors have demonstrated a good understanding of the subject matter and executed the study pretty well. I congratulate them for achieving this fit.

Reviewer #2: 1. The introduction section requires substantial improvement. It looks too very descriptive and not enough recent existing studies have been included. I would suggest adding more literatures and add a conceptual framework.

2. I understand that you have been given a word limit for the abstract, but I think authors should include a sentence informing the reader what the problem is and then move on to the sentence stating the aims of the paper.

3. The study does not discuss how the findings of this study connect to past research in this field. The authors should revise their Introduction to include references to the relevant literature, particularly newly published works by

Akhtar SN, Saikia N, Muhammad T (2023) Self-rated health among older adults in India: Gender specific findings from National Sample Survey. PLoS ONE 18(4): e0284321. https://doi.org/10.1371/journal.pone.0284321

Khan, M.R., Malik, M.A., Akhtar, S.N. et al. Multimorbidity and its associated risk factors among older adults in India. BMC Public Health 22, 746 (2022). https://doi.org/10.1186/s12889-022-13181-1

Akhtar, S.N. and Saikia, N. (2022), "Differentials and predictors of hospitalisation among the elderly people in India: evidence from 75th round of National Sample Survey (2017-2018)", Working with Older People, Vol. 26 No. 4, pp. 325-341. https://doi.org/10.1108/WWOP-11-2021-0055

Ahmed W, Muhammad T, Maurya C, Akhtar SN (2023) Prevalence and factors associated with undiagnosed and uncontrolled heart disease: A study based on self-reported chronic heart disease and symptom-based angina pectoris among middle-aged and older Indian adults. PLoS ONE 18(6): e0287455. https://doi.org/10.1371/journal.pone.0287455

Srivastava, S., Chauhan, S., & Patel, R. (2021). Socio-economic inequalities in the prevalence of poor self-rated health among older adults in India from 2004 to 2014: a decomposition analysis. Ageing International, 46(2), 182-199.

Chauhan, S., Patel, R., & Kumar, S. (2022). Prevalence, factors and inequalities in chronic disease multimorbidity among older adults in India: analysis of cross-sectional data from the nationally representative Longitudinal Aging Study in India (LASI). BMJ open, 12(3), e053953.

4. Please state, how your study is different from the previous existing studies? Justify!

5. Why the authors did not use the Chi-squared test? What do you mean by crude models? Do they measure the same thing – association? Why did you use these in the first place? What was the purpose?

6. As can be seen in Results, the authors have selected some variables that aren't mentioned in the section on explanatory variables. All the explanatory factors should be described in detail. The authors may choose to provide a table describing the various classifications and definitions of each explanatory variable. It increases the authenticity and replicability of work.

7. The mathematical expression of the model used in the study are missing in the methodology section. It is so generic expression. It should include the variables—or at least vectors of variables—for the actual regression in order to increase its value in the paper. As it stands, the generic equation does little beyond the description of variables above.

8. Why did the author included the socio-demographic distribution, if the author has not shown its association with the outcome variables? Justify.

9. What is the major drawback of this study?

10. Tables: All tables should have uniformly 2 decimals.

11. he discussion section is underdeveloped. The authors should highlight how the findings of this study contribute uniquely to the body of existing knowledge .

12. Any additional policy recommendation that focuses on particular states for the specific issues?

13. Please include the source, and captions for each figures properly.

14. There are many grammatical errors. Please revise.

15. Please check the writing format of PLOS. Rearrange the headings and subheadings.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: BOTHA, Nkosi Nkosi

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: REVIEW REPORT][3rd July, 23.doc

PLOS Glob Public Health. doi: 10.1371/journal.pgph.0002330.r003

Decision Letter 1

Miquel Vall-llosera Camps

16 Oct 2023

PGPH-D-23-01119R1

Exploring multimorbidity clusters in relation to healthcare use and its impact on self-rated health among older people in India

PLOS Global Public Health

Dear Dr. Hossain,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please address the remaining concerns by Reviewer#2: Revise your manuscript to provide a clear rationale for your study and contextualise your study relative to previous similar published works.

Please submit your revised manuscript by Nov 15 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Miquel Vall-llosera Camps

Staff Editor

PLOS Global Public Health

Journal Requirements:

1. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

2. We have noticed that you have uploaded Supporting Information files, but you have not included a list of legends. Please add a full list of legends for your Supporting Information files after the references list.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: (No Response)

**********

2. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have adequately addressed all issues raised making the manuscript good enough for publication.

Reviewer #2: The comments are not fully addressed. The literature section still required substantial revision. Also, the research question is unclear. The paper is very similar to the previous existing studies. There is no new significant findings.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: BOTHA, Nkosi Nkosi

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLOS Glob Public Health. doi: 10.1371/journal.pgph.0002330.r005

Decision Letter 2

Julia Robinson

22 Nov 2023

Exploring multimorbidity clusters in relation to healthcare use and its impact on self-rated health among older people in India

PGPH-D-23-01119R2

Dear Mr. Hossain,

We are pleased to inform you that your manuscript 'Exploring multimorbidity clusters in relation to healthcare use and its impact on self-rated health among older people in India' has been provisionally accepted for publication in PLOS Global Public Health.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact globalpubhealth@plos.org.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Global Public Health.

Best regards,

Julia Robinson

Executive Editor

PLOS Global Public Health

***********************************************************

Reviewer Comments (if any, and for reference):

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have adequately addressed all queries raised. Great job done.

Reviewer #2: No further comments.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: BOTHA, Nkosi Nkosi

Reviewer #2: No

**********

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: REVIEW REPORT][3rd July, 23.doc

    Attachment

    Submitted filename: Response to Reviewers.doc

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    The datasets generated and/or analyzed during the current study are available in the International Institute for Population Sciences (IIPS), Mumbai repository. A reasonable request for data access can be made at https://www.iipsindia.ac.in/content/LASI-data.


    Articles from PLOS Global Public Health are provided here courtesy of PLOS

    RESOURCES